UY29102A1 - Hexadecasacáridos biotinilados, su prepración y su utilización - Google Patents

Hexadecasacáridos biotinilados, su prepración y su utilización

Info

Publication number
UY29102A1
UY29102A1 UY29102A UY29102A UY29102A1 UY 29102 A1 UY29102 A1 UY 29102A1 UY 29102 A UY29102 A UY 29102A UY 29102 A UY29102 A UY 29102A UY 29102 A1 UY29102 A1 UY 29102A1
Authority
UY
Uruguay
Prior art keywords
hexadecasacarids
biotylated
prepration
moiety
alkoxy
Prior art date
Application number
UY29102A
Other languages
English (en)
Spanish (es)
Inventor
Petitou Maurice
Lormeau Jean-Claude
Choay Jean
Andre Bernat Jean-Marc Arnone
Philippe Duchaussoy
Jean Pascal Herault
Pierre Savi
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34948342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY29102(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of UY29102A1 publication Critical patent/UY29102A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
UY29102A 2004-09-09 2005-09-06 Hexadecasacáridos biotinilados, su prepración y su utilización UY29102A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0409557A FR2874924B1 (fr) 2004-09-09 2004-09-09 Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique

Publications (1)

Publication Number Publication Date
UY29102A1 true UY29102A1 (es) 2006-04-28

Family

ID=34948342

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29102A UY29102A1 (es) 2004-09-09 2005-09-06 Hexadecasacáridos biotinilados, su prepración y su utilización

Country Status (38)

Country Link
US (3) US20070270342A1 (cg-RX-API-DMAC7.html)
EP (1) EP1791872B1 (cg-RX-API-DMAC7.html)
JP (1) JP5108519B2 (cg-RX-API-DMAC7.html)
KR (1) KR101223364B1 (cg-RX-API-DMAC7.html)
CN (1) CN101039963B (cg-RX-API-DMAC7.html)
AR (1) AR051286A1 (cg-RX-API-DMAC7.html)
AT (1) ATE420118T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005284080B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0515078A (cg-RX-API-DMAC7.html)
CA (1) CA2577258C (cg-RX-API-DMAC7.html)
CY (1) CY1109126T1 (cg-RX-API-DMAC7.html)
DE (1) DE602005012287D1 (cg-RX-API-DMAC7.html)
DK (1) DK1791872T3 (cg-RX-API-DMAC7.html)
EA (1) EA012587B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP077272A (cg-RX-API-DMAC7.html)
ES (1) ES2320576T3 (cg-RX-API-DMAC7.html)
FR (1) FR2874924B1 (cg-RX-API-DMAC7.html)
GT (1) GT200500250A (cg-RX-API-DMAC7.html)
HN (1) HN2005000518A (cg-RX-API-DMAC7.html)
HR (1) HRP20090180T1 (cg-RX-API-DMAC7.html)
IL (1) IL181569A (cg-RX-API-DMAC7.html)
MA (1) MA28859B1 (cg-RX-API-DMAC7.html)
MX (1) MX2007002875A (cg-RX-API-DMAC7.html)
MY (1) MY140666A (cg-RX-API-DMAC7.html)
NI (1) NI200700063A (cg-RX-API-DMAC7.html)
NO (1) NO20071754L (cg-RX-API-DMAC7.html)
PA (1) PA8644201A1 (cg-RX-API-DMAC7.html)
PE (1) PE20060663A1 (cg-RX-API-DMAC7.html)
PL (1) PL1791872T3 (cg-RX-API-DMAC7.html)
PT (1) PT1791872E (cg-RX-API-DMAC7.html)
RS (1) RS50762B (cg-RX-API-DMAC7.html)
SI (1) SI1791872T1 (cg-RX-API-DMAC7.html)
SV (1) SV2006002221A (cg-RX-API-DMAC7.html)
TN (1) TNSN07053A1 (cg-RX-API-DMAC7.html)
TW (1) TW200612970A (cg-RX-API-DMAC7.html)
UY (1) UY29102A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006030104A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200702255B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912408A1 (fr) * 2007-02-14 2008-08-15 Sanofi Aventis Sa Heparine comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine,leur procede de preparation,leur utilisation
FR2912409B1 (fr) * 2007-02-14 2012-08-24 Sanofi Aventis Heparines de bas poids moleculaire comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine leur procede de preparation,leur utilisation
TW201006479A (en) * 2008-07-18 2010-02-16 Sanofi Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2233143A1 (en) * 2009-03-24 2010-09-29 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2145624A1 (en) * 2008-07-18 2010-01-20 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
FR2935387B1 (fr) * 2008-08-26 2010-09-10 Sanofi Aventis Hexadecasaccharides a activite antithrombotique comprenant une liaison covalente avec une chaine amine
FR2952935B1 (fr) 2009-11-20 2011-12-02 Sanofi Aventis Procede de preparation du n-biotinyl-6-aminocaproate de n succinimidyle

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU563351C (en) 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
EP0300099A1 (en) 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
IL102758A (en) 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
FR2704226B1 (fr) 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
ES2147216T3 (es) 1993-09-01 2000-09-01 Akzo Nobel Nv Bisconjugados que comprenden dos sacaridos y un grupo de union.
FR2751334B1 (fr) 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2773801B1 (fr) 1998-01-19 2000-05-12 Sanofi Sa Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
FR2773804B1 (fr) 1998-01-19 2000-02-18 Sanofi Sa Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine

Also Published As

Publication number Publication date
MA28859B1 (fr) 2007-09-03
SI1791872T1 (sl) 2009-06-30
EA200700594A1 (ru) 2007-08-31
PT1791872E (pt) 2009-03-27
NI200700063A (es) 2008-03-07
EP1791872A1 (fr) 2007-06-06
CA2577258A1 (fr) 2006-03-23
DK1791872T3 (da) 2009-05-04
CY1109126T1 (el) 2014-07-02
AU2005284080A1 (en) 2006-03-23
EP1791872B1 (fr) 2009-01-07
MY140666A (en) 2010-01-15
ECSP077272A (es) 2007-03-29
TW200612970A (en) 2006-05-01
AU2005284080B2 (en) 2011-10-13
DE602005012287D1 (de) 2009-02-26
FR2874924A1 (fr) 2006-03-10
US20100279960A1 (en) 2010-11-04
NO20071754L (no) 2007-04-02
HN2005000518A (es) 2009-06-01
SV2006002221A (es) 2006-01-13
PE20060663A1 (es) 2006-08-21
BRPI0515078A (pt) 2008-07-01
PA8644201A1 (es) 2006-05-16
US8557968B2 (en) 2013-10-15
HRP20090180T1 (en) 2009-05-31
ES2320576T3 (es) 2009-05-25
KR101223364B1 (ko) 2013-01-16
US20130004551A1 (en) 2013-01-03
AR051286A1 (es) 2007-01-03
US8703738B2 (en) 2014-04-22
FR2874924B1 (fr) 2006-12-01
TNSN07053A1 (fr) 2008-06-02
RS50762B (sr) 2010-08-31
ZA200702255B (en) 2008-09-25
CN101039963B (zh) 2011-07-27
HK1113686A1 (en) 2008-10-10
GT200500250A (es) 2006-04-10
US20070270342A1 (en) 2007-11-22
IL181569A0 (en) 2007-07-04
JP2008512538A (ja) 2008-04-24
MX2007002875A (es) 2007-05-16
EA012587B1 (ru) 2009-10-30
KR20070051887A (ko) 2007-05-18
CN101039963A (zh) 2007-09-19
CA2577258C (fr) 2013-05-21
ATE420118T1 (de) 2009-01-15
WO2006030104A1 (fr) 2006-03-23
IL181569A (en) 2011-08-31
PL1791872T3 (pl) 2009-06-30
JP5108519B2 (ja) 2012-12-26

Similar Documents

Publication Publication Date Title
UY26782A1 (es) Derivados del benzotiazol
CR9587A (es) Derivados de piridazina
HRP20120323T1 (en) Diarylhydantoin compounds
UY31674A1 (es) Derivado heterocíclico fusionado y su uso
CR9703A (es) Derivados de pirazolona
CR8147A (es) Derivados de pirido 2, 1a-isoquinolina, como inhibidores de dpp-iv
CR9234A (es) Derivados de 2,4(4,6) pirimidina
TW200608972A (en) Aryl-pyridine derivatives
CR9980A (es) Imidazolinas 4,4,5,5 tetrasustituidas
PE20090362A1 (es) Derivados de piperidina/piperazina como moduladores de dgat
AR044650A1 (es) Derivados de tiofeno - pirimidinona y su uso en la terapia de enfermedades que requieren la inhibicion de la enzima 17b-hidroxiesteroide-dehidrogenasa.
AR072261A1 (es) Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos.
CU20100200A7 (es) Una composición farmacéutica que comprende n-(3,4-difluoro-2-4-iodofenilamino)-6-metoxifenil)-l-(2,3-dihidroxipropil)ciclopropano-l-sulfonamida, útil para el tratamiento y prevención del cáncer y de enfermedades inflamatorias
CR9947A (es) Compuestos de pirimidinil benzotiofeno
ES2571779T3 (es) Inhibidores de cinasa a base de nicotinamida
CO6241123A2 (es) Moduladores de la gamma secretasa
NO20064077L (no) Kemokinreseptorantagonister
ECSP099062A (es) Derivados novedosos de aminopiridina que tienen acción inhibidora selectiva sobre aurora a
NI200700063A (es) Hexadecasacáridos biotinilados, su preparación y su utilización.
ECSP066542A (es) Derivados de disulfuro, sulfuro, sulfóxido, y sulfota de azúcares cíclicos y sus usos
AR024494A1 (es) Proceso para la preparacion de derivados de ciclopentano sustituido y novedosas estructuras cristalinas de los mismos
PA8579301A1 (es) Derivados de tiazol
UY29170A1 (es) Adeninas sustituidas y usos de las mismas
AR058348A1 (es) Derivados de 1-aza-biciclo-nonano y composiciones farmaceuticas que los comprenden
UY26847A1 (es) Derivados de la pirrolidina

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160530